Tsang-En Wang
Overview
Explore the profile of Tsang-En Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
985
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen L, Yeh K, Lin C, Wang T, Wang M, Hsiao C, et al.
Am J Hematol
. 2025 Feb;
PMID: 39912311
No abstract available.
2.
Kang C, Wang T, Liu C, Chen M, Wang H, Chang C, et al.
J Med Ultrasound
. 2024 Jun;
32(2):116-120.
PMID: 38882614
Nonalcoholic fatty liver disease (NAFLD), among the most common chronic liver diseases worldwide, affects approximately 25% of the global population. Its incidence is increasing owing to various risk factors, including...
3.
Yen C, Yang Y, Ku H, Hu H, Lo S, Chang H, et al.
Cancer Med
. 2023 Jul;
12(16):16906-16917.
PMID: 37401402
Background: Gastrectomy remains the curative option in gastric cancer. However, the growing concern that preoperative waiting jeopardizes survival has not been fully addressed. The present population-based cohort study aimed to...
4.
Kee K, Chen C, Hu J, Huang Y, Wang T, Chau G, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680166
Hepatocellular carcinoma (HCC) is a major cause of cancer death in Taiwan, and in the past 30-40 years, Taiwan has been committed to its prevention and treatment. We aimed to...
5.
Huang Y, Wang T, Chen M, Lin C, Chang C, Tai H, et al.
Front Oncol
. 2022 Oct;
12:906498.
PMID: 36203419
Background: This study aims to establish and validate a predictive model based on radiomics features, clinical features, and radiation therapy (RT) dosimetric parameters for overall survival (OS) in hepatocellular carcinoma...
6.
Lin S, Lin C, Hsu N, Yen Y, Kee K, Wang J, et al.
J Formos Med Assoc
. 2022 Apr;
121(10):2085-2092.
PMID: 35450743
Background/purpose: Controversies over the use of alpha-fetoprotein (AFP) for detection of hepatocellular carcinoma (HCC) existed from guidelines. Using large-scale database and hospital-based information, we aimed to reappraise the role of...
7.
Hu H, Tsai H, Ku H, Lo S, Shan Y, Chang H, et al.
Sci Rep
. 2021 Dec;
11(1):23142.
PMID: 34848751
Chemotherapy is generally considered as the main treatment for metastatic gastric adenocarcinoma. The role of gastrectomy for metastatic gastric cancer without obvious symptoms is controversial. The objective of this study...
8.
Lin W, Lin Y, Chang C, Chang C, Wang T, Wang H, et al.
PLoS One
. 2020 May;
15(5):e0233212.
PMID: 32442193
With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma...
9.
Chang C, Lee H, Li L, Chiang Chiau J, Wang T, Chuang W, et al.
Int J Mol Sci
. 2020 Jan;
21(2).
PMID: 31936237
FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin), a 5-fluorouracil (5-FU)-based chemotherapy regimen, is one of most common therapeutic regimens for colorectal cancer. However, intestinal mucositis is a common adverse effect for which...
10.
Tsai H, Tai J, Chen L, Wu M, Yeh K, Lin C, et al.
Haematologica
. 2019 Nov;
105(7):e349-e354.
PMID: 31727764
No abstract available.